Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements

Chinese Medical Journal

Volumn 110, Issue 9, 1997, Pages 694-697

  Ren, Mingshan ^a   Yang, Renmin ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; IRON; SUCCIMER; TRACE ELEMENT; ZINC;

ADOLESCENT; ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BILE LEVEL; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DYSPHAGIA; DYSPHASIA; ECCHYMOSIS; EPISTAXIS; FEMALE; GINGIVA DISEASE; HUMAN; HYPERPIGMENTATION; MALE; MYOTONIA; ORAL DRUG ADMINISTRATION; SALIVATION; SCHOOL CHILD; URINE LEVEL; WILSON DISEASE;

ADOLESCENT; ADULT; ANTIDOTES; BILE; CHILD; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; IRON; MALE; SUCCIMER; TRACE ELEMENTS; ZINC;

EID: 9844268500     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ting KS, Liang YI, Shi J, et al. Chelate stability of sodium dimercaptosuccinate on the intoxications from many metals. Chin Med J 1965; 51:304.
2. Scheinberg IH, Sternlieb I. Major problems in internal medicine: Wilson's disease. 2nd ed. Philadelphia, W. B. Saunders, 1984:86-92.
3. Walshe JM. Wilson's disease. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology (vol. 5): extrapyramidal disorders. Amsterdam: Elsevier, 1986:223-228.
4. Yang YF. Normal copper metabolism and etiological mechanism of HLD. Chin J Nerv Ment Dis 1984; 10:61.
5. Gibbs Ki Walshe JM. Biliary excretion of copper in Wilson's disease. Lancet 1980; 2:538.
6. Lyengar V, Brewer GJ, Dick RD, et al. Studies of the cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease. J Lab Clin Med 1988; 111:267.
7. Aposhian HV. DMSA and DMPS water soluble antidotes for heavy metal poisoning. Ann Rev Pharmacol Toxicol 1983; 23:204.
8. Brewer GJ, Hill GM, Prasod AS, et al. Oral zinc for Wilson's disease. Ann Intern Med 1983; 99:319.
9. Aposhian HV, Tadlock CH, Moon TE. Protection of mice against the lethal effects of sodium - arsenite: a quantitative comparison of a number of chelating agents. Toxicol Appl Pharmacol 1981; 61:385.
10. Friedheim E, Corvi C, Wakker CH. Meso-dimercaptosuccinic acid: a chelating agent for the treatment of mercury and iead poisoning. J Pharm Pharmacol 1976; 28:711.